| Authors: |
Zarba M; Arthur Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada. Electronic address: Martin.Zarba@albertahealthservices.ca., Maj D; Arthur Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada., Chehade REH; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Semaan K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wells JC; Arthur Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada., Donskov F; Department of Medical Oncology, Aarhus University Hospital, Aarhus, Denmark., McKay RR; Department of Medical Oncology, University of California San Diego, San Diego, CA., Sade JP; Department of Medical Oncology, Instituto Alexander Fleming, Buenos Aires, Argentina., Takemura K; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Wood LA; Department of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS., Davis ID; Department of Medical Oncology, Monash University Eastern Health Clinical School, Melbourne, Australia., Vaishampayan U; Department of Medical Oncology, University of Michigan Medical Center, Ann Arbor, MI., Basterretxea L; Department of Medical Oncology, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Porta C; Department of Medical Oncology, Policlinico Consorziale, Bari, Italy., Suarez C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., de Velasco G; Guillermo de Velasco, Hospital Universitario 12 de Octubre, Madrid, Spain., Moradi A; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA., Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Heng DYC; Arthur Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada. |
